Theracryf annual free cash flow
2022
2023
Theracryf Free Cash Flow (FCF) History (TCF)
Theracryf reported −£4.1M in free cash flow for fiscal 2023, a decrease of £1.5M from the previous fiscal year, with a free cash flow margin of −933.94%.
View full Theracryf company overviewTheracryf free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-03-31 | −£4.1M | −£1.5M | — | −933.94% |
| 2022 | 2022-03-31 | −£2.6M | — | — | — |
Theracryf free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Theracryf source filings ↗Community posts
TheraCryf approves £1.05m capital raise and share-capital reorganisation
TheraCryf confirmed on 7 September 2026 that shareholders approved its approximately £1.05m gross capital raise and the related subdivision of share capital. Shares and dates The placing and subscription will issue 583,333,328 new ordinary ...